Who Owns Equate?

Equate's sustainability profile is tied to Walmart's corporate ESG framework. Walmart has set environmental targets including zero emissions across its operations by 2040 and a commitment to protect, restore, or sustainably manage at least 50 million acres of land and 1 million square miles of ocean by 2030.

For Equate products, the primary sustainability considerations are packaging waste and supply chain ethics. Walmart has committed to reducing plastic waste in private label packaging, including transitioning to recyclable, reusable, or compostable packaging. Equate packaging has been gradually updated to reduce plastic content and increase use of recycled materials.

Walmart's Standards for Suppliers require all contract manufacturers, including those producing Equate products, to comply with labor, safety, and environmental standards. The standards prohibit forced labor, child labor, and unsafe working conditions. Suppliers are audited for compliance.

On animal testing, Walmart's private label beauty products, including Equate, are not certified cruelty-free. Walmart does not have a formal cruelty-free policy for its private label brands. This is a point of criticism from animal welfare advocacy groups.

The 2024 eye ointment recall raised questions about quality oversight at international contract manufacturing facilities. The recall involved products manufactured by Brassica Pharma Pvt. Ltd. in India, where FDA inspection found sterility assurance issues. This highlighted the challenge of maintaining quality standards across a global network of contract manufacturers.

Equate has faced product recalls, primarily related to manufacturing quality issues at contract manufacturing facilities. The brand has not faced systemic safety controversies, but individual product recalls have occurred.

Eye Ointment Recall (February 2024): In February 2024, Brassica Pharma Pvt. Ltd. voluntarily recalled Equate Lubricant Eye Ointment and Equate Stye Lubricant Eye Ointment due to potential lack of sterility assurance. The FDA announced the recall for products with expiration dates from February 2024 to September 2025. The recall was initiated after an FDA inspection of the Brassica Pharma manufacturing facility in India revealed sterility assurance issues. No adverse events were reported, but the potential lack of sterility posed a risk of eye infections. This recall highlighted the quality control challenges of sourcing OTC products from international contract manufacturers.

Quality Control Across Contract Manufacturers: Equate products are manufactured by dozens of contract manufacturers across multiple countries. Maintaining consistent quality across this network is an ongoing challenge. The eye ointment recall demonstrated that FDA inspections can identify manufacturing deficiencies at facilities producing Equate products. Walmart relies on supplier audits and FDA inspections to ensure quality, but gaps can occur.

Pricing and Quality Perception: Equate faces ongoing perception challenges from consumers and competitors who question whether lower-priced private label products are equivalent in quality to national brands. Multiple consumer testing organizations, including Consumer Reports, have tested Equate products and found them to be equivalent in active ingredient content and efficacy to national brands. However, the perception gap persists among some consumers.

Animal Testing: Equate beauty and personal care products are not certified cruelty-free. Walmart does not have a formal cruelty-free certification for its private label brands. This has drawn criticism from animal welfare organizations and consumers who prefer cruelty-free products.

Supply Chain Transparency: Walmart discloses limited information about the specific contract manufacturers that produce Equate products. Unlike national brands that prominently feature their manufacturing facilities and quality certifications, Equate products do not identify the manufacturer on packaging. This lack of transparency has been criticized by consumer advocacy groups.

Walmart Corporate Controversies: As a Walmart private label brand, Equate is indirectly affected by controversies surrounding Walmart's labor practices, competitive impact on local businesses, and supply chain ethics. These controversies do not directly involve Equate products but can affect consumer perception of Walmart's private label brands.